Stamatina Papakonstantinou NEPHROLOGIST

6944 442 041
210 686 7000
spapakonstantinou@hygeia.gr

Education & Academic Qualifications

23/09/1996: Graduate of Medical University of Sofia, Bulgaria
23/12/2005: Awarded Nephrology specialty title after exams

Fellowship in Societies, Membership in Journal Editorial Committees

Hellenic Nephrology Society (ENE)
European Renal Association – European Dialysis and Transplant Association (ERA-EDTA)
International Society of Nephrology (ISN)

Work Experience

Countryside service, Community Health Center of Siatista, General Hospital of Kozani, 1997 – 1999
Residency in Internal Medicine, General Hospital of Veroia, 1999 – 2001
Residency in Nephrology, General Hospital of Veroia, 2001- 2005
Residency in Renal Transplantation, Hippokration General Hospital of Thessaloniki, Organ Transplant Clinic, 2005
Nephrologist, Dialysis Unit, Hygeia Hospital Athens, 2005 – 2009
Nephrologist, Nephrology Institute Athens, 2009 – 2012
Nephrologist, Scientific partner/contributor, Hygeia Hospital Athens since 2012

Clinical & Research Interest

Clinical Interest:

Diagnostic approach and treatment of Acute Kidney Injury (AKI) and Chronic Kidney Disease (CKD)
Hemodialysis treatment versions (Chronic Dialysis, Acute Dialysis, Continuous Renal Replacement Therapy)
Diagnosis and Treatment of primary and secondary renal diseases
Diagnosis and Treatment of Arterial Hypertension
Diabetic Nephropathy
Metabolic Workup of Renal Lithiasis
Geriatric Nephrology

Research Interest:

Complications of CKD
Renal Anemia
Renal Bone Disease, Secondary Hyperparathyroidism
Renal Nutrition

Researcher in Greek and International multicenter clinical trials:

NESP 20000259 phase IIIb
ΜΟ1-367
AURORA STUDY

Recent Publications

Beneficial effect of atorvastatin on erythropoietin responsiveness in maintenance haemodialysis patients, Nephrology, Volume 14 Issue 6, Pages 560 – 564, Published Online: 3 Mar 2009
Prevalence of the metabolic syndrome in hemodialysis, Int J Artif Organs 2007 Feb; 30 (2): 118-23
Platelet GP IIIA polymorphism HPA-1 (PLA1/2) is associated with hypertension as the primary cause for end-stage renal disease in hemodialysis patients from Greece, In Vivo January 1, 2009 vol. 23 no. 1, 177-181
Characteristics of uremic pruritus in hemodialysis patients: data from a single center, Kidney International (2008) 74, 962; doi:10.1038/ki.2008.359
Loss of hepatitis b immunity in hemodialysis patients acquired either naturally or after vaccination, Clinical Nephrology, Volume 68, No. 4/2007
Unit dosing of darbepoetin alfa for the treatment of anemia in patients with esrd being switched from recombinant human erythropoietin: results of a phase ΙΙΙb, 27-week, multicenter, open-label study in greek patients, Current Therapeutic Research, vol.66, no 3, May/June 2005
A rare case of peritonitis caused by flavimonas oryzihabitans in continuous ambulatory peritoneal dialysis, Geriatric Nephrology and Urology, (2005) 37: 433-436
Δέκα χρόνια εμπειρίας στη συνεχή φορητή περιτοναϊκή κάθαρση (ΣΦΠΚ) σε ένα κέντρο δευτεροβάθμιας περίθαλψης, Ελληνική Νεφρολογία 2004; 16 (1): 76-82
Υποτροπιάζουσες και de novo σπειραματονεφρίτιδες στο νεφρικό μόσχευμα, Ελληνική Νεφρολογία 2004; 16 (2): 127-135
Η εφαρμογή των κατευθυντηρίων οδηγιών στην κλινική πράξη, Ελληνική νεφρολογία 2006; 18 (1): 27-33